Followers | 17 |
Posts | 1957 |
Boards Moderated | 1 |
Alias Born | 09/27/2020 |
![](https://investorshub.advfn.com/uicon/760444.png?cb=1664148451)
Wednesday, February 07, 2024 8:36:17 PM
There are only two possible outcomes from this point, IMO.
1. The court approves the reorganization plan and the company gets another chance, and the stock continues to trade. Whether the company succeeds following reorganization is anyone's guess. But the lawsuit the company has against certain clients is approximately $5M, which is enough to resolve all issues presented to the Israeli courts by the former CEO and 3CL Pharma. But if those companies don't have the cash or the liability insurance to pay the claims if Todos wins the lawsuits, this point is moot.
2. The court does not approve the reorganization plan and the company's assets are liquidated. The stock would stop trading, and shareholders would lose their entire investment.
The stock continues to trade because some feel option 1 is possible. One can purchase 1M shares for only $200 at this point. For some this may be a low-cost lottery ticket for 1-100x return in the coming months. Others may simply be exiting their position to get whatever they can for their remaining shares. MMs may be buying large numbers of shares from those selling to resell to the speculators at 100% profit. I expect the large trading volume will continue until there is news regarding the insolvency proceedings, or the transfer agent halts trading of shares.
There may be another scenario I haven't considered. But in most liquidations, note holders and preferred stock holders are given priority over any funds generated. Common shareholders are low on the recovery totem pole and rarely get anything. I don't believe note holders would be buying the shares we see trading now. They already have a claim in liquidation. I believe it's mainly speculators and MMs generating most of the volume on the buy side from investors who are exiting their positions.
Actually, one other unlikely scenario comes to mind. According to GC's LinkedIn page, he's a managing partner at Fortitude Advisors LLC, which are merger and acquisition experts according to their website. Is it possible something is being pursued there to have Todos Medical acquired by or merged with another company? Perhaps that's what some of the speculators are considering. I am not one of those, but just pointing out a remote possibility. Gerald did say he would find a way to keep Tollovid production going for those who need it.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM